Scientific Advisory Board| Friends of Cancer Research

Scientific Advisory Board

Edward Benz, Jr., M.D. President, Dana-Farber Cancer Institute, Harvard

G. Denman Hammond, M.D. Founder & Trustee, National Childhood Cancer Foundation

Frank McCormick, Ph.D., F.R.S. Director, UCSF Comprehensive Cancer Center

Joseph Bertino, M.D. Director, The Cancer Institute of New Jersey

Leland H. Hartwell, Ph.D. President & Director, Fred Hutchinson Cancer Research Center

Harold L. Moses, M.D. Director Emeritus, Vanderbilt-Ingram Cancer Center

Bruce A. Chabner, M.D. Clinical Director, Massachusetts General Hospital Cancer Center

Peter A. Jones, Ph.D., D.S.C. Director, Norris Comprehensive Cancer Center

Larry Norton, M.D. Deputy Physician-in-Chief, Memorial Sloan-Kettering Cancer Center

William S. Dalton, M.D., Ph.D. CEO & Center Director, Moffitt Cancer Center

Eric S. Lander, Ph.D. Director, Broad Institute of MIT and Harvard

Ivor Royston, M.D. Founding Managing Partner, Forward Ventures

Michael A. Friedman, M.D. President & CEO, City of Hope Cancer Center

Scott Lippman, M.D. Chair, Department of Clinical Cancer Prevention, M.D. Anderson

Richard L. Schilsky, M.D. Assoc. Dean for Clinical Research, University of Chicago

Judith C. Gasson, Ph.D. Director, UCLA/Jonsson Comprehensive Cancer Center

H. Kim Lyerly, M.D. Director, Duke Comprehensive Cancer Center

Jerome W. Yates, M.D., M.P.H. National Vice President for Research (Ret.) ACS

John L. Marshall, M.D. Chief, Division of Hematology Oncology, Lombardi CCC

Robert C. Young, M.D. Chancellor, Fox Chase Cancer Center